NINL and diffuse large B-cell lymphoma: Among the seven lncRNAs included in the risk model, LINC00654 has been identified as the hub lncRNA in DLBCL patients, and LncRNA00654-NINL mRNA regulatory axis could be involved in DLBCL progression36.